Growth Metrics

Invivyd (IVVD) Total Liabilities (2020 - 2025)

Invivyd posted quarterly Total Liabilities of $35.3 million for Q4 2025, down 42.97% year-on-year from $62.0 million in Q4 2024, and down 23.32% on a QoQ basis from $46.1 million in Q3 2025.

Invivyd (IVVD) has 6 years of Total Liabilities data on file, last reported at $35.3 million in Q4 2025.

  • For the quarter ending Q4 2025, Total Liabilities fell 42.97% year-over-year to $35.3 million; the trailing twelve-month figure through Dec 2025 stood at $35.3 million (down 42.97% YoY), and the FY2025 full-year result was $35.3 million, down 42.97% from the prior year.
  • Total Liabilities for Q4 2025 stood at $35.3 million, down from $46.1 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $103.4 million in Q1 2021 and bottomed at $23.8 million in Q1 2023.
  • The 5-year median for Total Liabilities is $46.8 million (2022), against an average of $51.4 million.
  • The widest annual swing landed in 2021, when Total Liabilities jumped 374.45%; it then plunged 75.42% in 2023.
  • A 5-year view of Total Liabilities shows it stood at $62.1 million in 2021, then sank by 56.18% to $27.2 million in 2022, then soared by 90.14% to $51.7 million in 2023, then gained by 19.85% to $62.0 million in 2024, then plunged by 42.97% to $35.3 million in 2025.
  • The last three Total Liabilities figures came in at $35.3 million (Q4 2025), $46.1 million (Q3 2025), and $46.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 16.35 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1.74 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 731.60 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 177.22 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 19.51 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 7.12 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 10.44 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 9.45 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.05 Bn
10 Invivyd 208.38 Mn -18.31 Mn - 35.34 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 35.34 Mn
Sep 30, 2025 46.09 Mn
Jun 30, 2025 46.35 Mn
Mar 31, 2025 49.60 Mn
Dec 31, 2024 61.98 Mn
Sep 30, 2024 78.76 Mn
Jun 30, 2024 36.70 Mn
Mar 31, 2024 36.97 Mn
Dec 31, 2023 51.71 Mn
Sep 30, 2023 28.42 Mn
Jun 30, 2023 33.85 Mn
Mar 31, 2023 23.82 Mn
Dec 31, 2022 27.20 Mn
Sep 30, 2022 47.30 Mn
Jun 30, 2022 69.77 Mn
Mar 31, 2022 96.88 Mn
Dec 31, 2021 62.07 Mn
Sep 30, 2021 53.06 Mn
Jun 30, 2021 37.91 Mn
Mar 31, 2021 103.36 Mn
Dec 31, 2020 13.08 Mn